Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PHTF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ABI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MUC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNEP1R1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KAT6A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
APH1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSD17B11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPSF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM63B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDFIC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00658 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ODF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCTE3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASXL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on